NanoString Technologies (NSTG) Tops Q2 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
NanoString Technologies Releases Operating Results for Second Quarter of 2017
August 8, 2017 4:03 PM EDTSEATTLE, Aug. 08, 2017 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the second quarter of 2017.Â
Second Quarter Financial HighlightsÂ
Total revenue of $34.6 million, 53% year-over-year growthTotal product and service revenue of $18.3 million, 5% year-over-year growthConsumables revenue of $11.0 million, including $1.8 million of Prosigna® IVD kits, 7% year-over-year growthInstrument revenue of $6.0 million, 6% year-over-year declineCollaboration revenue of $16.3 million, including $11.3 million related to the terminated Medivation and Astellas collaboration... More